Couch FJ - Search Results

1

Racial disparity in breast cancer and functional germ line mutation in galectin-3 (rs4644): a pilot study.

Balan V, Nangia-Makker P, Schwartz AG, Jung YS, Tait L, Hogan V, Raz T, Wang Y, Yang ZQ, Wu GS, Guo Y, Li H, Abrams J, Couch FJ, Lingle WL, Lloyd RV, Ethier SP, Tainsky MA, Raz A. Balan V, et al. Among authors: couch fj. Cancer Res. 2008 Dec 15;68(24):10045-50. doi: 10.1158/0008-5472.CAN-08-3224. Cancer Res. 2008. PMID: 19074869 Free PMC article.

2

Transcript identification in the BRCA1 candidate region.

Weber BL, Abel KJ, Couch FJ, Merajver S, Castilla L, Brody LC, Collins FS. Weber BL, et al. Among authors: couch fj. Breast Cancer Res Treat. 1995;33(2):115-24. doi: 10.1007/BF00682719. Breast Cancer Res Treat. 1995. PMID: 7749139 Free article. Review.

3

Familial breast cancer. Approaching the isolation of a susceptibility gene.

Weber BL, Abel KJ, Brody LC, Flejter WL, Chandrasekharappa SC, Couch FJ, Merajver SD, Collins FS. Weber BL, et al. Among authors: couch fj. Cancer. 1994 Aug 1;74(3 Suppl):1013-20. doi: 10.1002/1097-0142(19940801)74:3+<1013::aid-cncr2820741507>3.0.co;2-#. Cancer. 1994. PMID: 8039134 Review.

4

BRCA1 and BRCA2 have a limited role in familial prostate cancer.

Sinclair CS, Berry R, Schaid D, Thibodeau SN, Couch FJ. Sinclair CS, et al. Among authors: couch fj. Cancer Res. 2000 Mar 1;60(5):1371-5. Cancer Res. 2000. PMID: 10728701

5

Structural analysis of the 17q22-23 amplicon identifies several independent targets of amplification in breast cancer cell lines and tumors.

Wu G, Sinclair C, Hinson S, Ingle JN, Roche PC, Couch FJ. Wu G, et al. Among authors: couch fj. Cancer Res. 2001 Jul 1;61(13):4951-5. Cancer Res. 2001. PMID: 11431322

6

TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumors.

Sinclair CS, Adem C, Naderi A, Soderberg CL, Johnson M, Wu K, Wadum L, Couch VL, Sellers TA, Schaid D, Slezak J, Fredericksen Z, Ingle JN, Hartmann L, Jenkins RB, Couch FJ. Sinclair CS, et al. Among authors: couch fj, couch vl. Cancer Res. 2002 Jul 1;62(13):3587-91. Cancer Res. 2002. PMID: 12097257

7

Utilizing Nottingham Prognostic Index in microarray gene expression profiling of breast carcinomas.

Miller DV, Leontovich AA, Lingle WL, Suman VJ, Mertens ML, Lillie J, Ingalls KA, Perez EA, Ingle JN, Couch FJ, Visscher DW. Miller DV, et al. Among authors: couch fj. Mod Pathol. 2004 Jul;17(7):756-64. doi: 10.1038/modpathol.3800114. Mod Pathol. 2004. PMID: 15073601 Free article.

8

Germ line Fanconi anemia complementation group C mutations and pancreatic cancer.

Couch FJ, Johnson MR, Rabe K, Boardman L, McWilliams R, de Andrade M, Petersen G. Couch FJ, et al. Cancer Res. 2005 Jan 15;65(2):383-6. Cancer Res. 2005. PMID: 15695377

9

Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes.

Goetz MP, Rae JM, Suman VJ, Safgren SL, Ames MM, Visscher DW, Reynolds C, Couch FJ, Lingle WL, Flockhart DA, Desta Z, Perez EA, Ingle JN. Goetz MP, et al. Among authors: couch fj. J Clin Oncol. 2005 Dec 20;23(36):9312-8. doi: 10.1200/JCO.2005.03.3266. J Clin Oncol. 2005. PMID: 16361630

10

A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifen.

Goetz MP, Suman VJ, Ingle JN, Nibbe AM, Visscher DW, Reynolds CA, Lingle WL, Erlander M, Ma XJ, Sgroi DC, Perez EA, Couch FJ. Goetz MP, et al. Among authors: couch fj. Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2080-7. doi: 10.1158/1078-0432.CCR-05-1263. Clin Cancer Res. 2006. PMID: 16609019 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

637 results

Search Page